FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 328:1496-1497 May 20, 1993 Number 20 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

To the Editor: Robertson (Dec. 24 issue)¹ contends that pancreatic transplantation should no longer be considered an experimental procedure. I do not understand how he can reach this conclusion, when the proper use and results of pancreatic transplantation remain in question. Other less complicated transplantation procedures, such as allogeneic and autologous bone marrow transplantation, are considered experimental for some diseases because of the lack of efficacy and the unacceptable morbidity and mortality associated with the therapy that accompanies these procedures. Technical success in transplanting the graft is not the sole determinant of whether a procedure should no longer be considered . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.